|
|
Volumn 61, Issue 4, 2006, Pages 240-242
|
|
Intraperitoneal cisplatin and paclitaxel in ovarian cancer: Commentary
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CREATININE;
PACLITAXEL;
ABDOMINAL PAIN;
BLOOD CELL COUNT;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CATHETER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE COURSE;
DOSE RESPONSE;
FATIGUE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
KIDNEY FUNCTION;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
METABOLIC DISORDER;
NEUROTOXICITY;
NEUTROPHIL COUNT;
NOTE;
OVARY CANCER;
PAIN;
PHASE 3 CLINICAL TRIAL;
QUALITY OF LIFE;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SURFACE PLASMON RESONANCE;
THROMBOCYTE COUNT;
|
|
EID: 33645416116
PISSN: 00297828
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ogx.0000206353.22975.c5 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
